LDHA通过代谢与表观遗传重编程诱导糖尿病β细胞去分化
研究在人类2型糖尿病供体胰岛、db/db小鼠和高脂饮食诱导糖尿病小鼠中分析LDHA表达与活性,发现抑制LDHA可保留β细胞身份、改善胰岛素输出和糖稳态。机制上LDHA激活增加Sox9、Hes1和Aldh1a3启动子区H3K9la并促进其转录,触发β细胞去分化。
要点
- 抑制LDHA可延缓空腹血糖受损个体疾病进展并改善糖尿病模型糖稳态
- LDHA激活通过增加H3K9la促进Sox9、Hes1和Aldh1a3转录
- LDHA抑制可能是糖尿病治疗的新策略
核心结论
- LDHA介导的代谢与表观遗传重编程在糖尿病发展中驱动β细胞去分化,抑制LDHA可能是糖尿病治疗新策略。
研究设计与样本
- 在人类2型糖尿病供体胰岛、高血糖db/db小鼠和高脂饮食诱导糖尿病小鼠中分析LDHA表达与活性。
- 在高脂饮食喂养小鼠和db/db小鼠中研究LDHA抑制对β细胞功能和身份的影响。
- 采用ChIP-seq和RNA-seq研究LDHA影响H3K9la增加及高糖毒性下β细胞功能的分子机制。
主要发现
- 抑制LDHA有效保留β细胞身份,延缓空腹血糖受损个体疾病进展,并改善糖尿病模型胰岛素输出和糖稳态。
- LDHA激活导致β细胞去分化标志基因Sox9、Hes1和Aldh1a3启动子区H3K9la显著增加并促进其转录。
- 上述机制触发小鼠β细胞去分化以及糖稳态和β细胞功能受损。
临床怎么用
- LDHA抑制可能作为保留β细胞身份、改善糖尿病糖稳态的潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Pancreatic beta cell dedifferentiation underlies the reversible reduction in beta cell mass and function in diabetes. Exploratory research into interventional targets and adjuvant therapies to prevent or reverse beta cell dedifferentiation and transdifferentiation may provide evidence to support the effective treatment of diabetes, although the underlying molecular mechanism remains elusive. METHODS: Lactate dehydrogenase A (LDHA) expression and activity were analysed in islets obtained from human donors with type 2 diabetes, hyperglycaemic db/db mice and a high-fat diet (HFD)-induced mouse model of diabetes. The impact of LDHA inhibition on beta cell function and identity was also investigated in HFD-fed mice and db/db mice. Chromatin immunoprecipitation (ChIP)-seq and RNA-seq were used to investigate the specific molecular mechanism underlying the effect of LDHA on histone H3 lysine 9 lactylation (H3K9la) increases and beta cell function under glucotoxic conditions. RESULTS: We demonstrate that inhibition of LDHA effectively preserves beta cell identity, which not only delays disease progression in individuals with impaired fasting glucose, but also improves insulin output and glucose homeostasis in diabetic models. Mechanistically, activation of LDHA led to a marked increase in H3K9la in the promoter region of the beta cell dedifferentiation marker genes Sox9, Hes1 and Aldh1a3, and facilitated their transcription, thereby triggering beta cell dedifferentiation as well as impaired glucose homeostasis and beta cell function in mice. CONCLUSIONS/INTERPRETATION: We unravelled the role of LDHA-mediated metabolic and epigenetic reprogramming in beta cell dedifferentiation during diabetes development. This study suggests that LDHA inhibition could be a novel therapeutic strategy for diabetes treatment.
引用
- Li X, Gong H, Xiong C, et al. LDHA induces beta cell dedifferentiation in diabetes through metabolic and epigenetic reprogramming. Diabetologia. 2025. PMID: 41381887. doi:10.1007/s00125-025-06626-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。